Janssen Biotech

• NCT02315326

  Collaborator, Phase 1/2, Completed, 93 people, 11 Dec 2014

• NCT02309580

  Collaborator, Phase 1, Completed, 14 people, 5 Dec 2014

• NCT01959399

  Collaborator, Phase 1, Completed, 24 people, 10 Oct 2013

• NCT01637402

  Collaborator, Phase 2, Completed, 41 people, 11 Jul 2012

• NCT01314118

  Phase 2, Completed, 131 people, 14 Mar 2011

• NCT01004432

  Phase 3, Completed, 433 people, 30 Oct 2009

• Integrating glucagon-like peptide-1 receptor agonists into dermatology practice: Safety and monitoring strategies

  Consulting or advice, Board or leadership role, 6 Aug 2026

• A High-Fiber, Plant-Based Diet in Myeloma Precursor Disorders: Results from the NUTRIVENTION Clinical Trial and Preclinical Vk*MYC Model

  Fees or honoraria, 1 Apr 2026

Sources: pubmed.ncbi.nlm.nih.gov